Table 1 Patient characteristics
| Â | No. of patients (%) |
|---|---|
Age (years) | |
 Median | 50 |
 Range | 15–84 |
Gender | Â |
 Male | 51 (51.5) |
 Female | 48 (48.5) |
Any chronic comorbidity | |
 No | 72 (72.7) |
 Yes | 27 (27.3) |
Tumor site | |
 Lower extremity | 73 (73.7) |
 Upper extremity | 26 (26.3) |
Tumor size (cm) | |
  ≤ 5 | 34 (34.3) |
  > 5 | 61 (61.6) |
 Unknowna | 4 (4.0) |
Tumor depth | |
 Superficial | 30 (30.3) |
 Deep | 69 (69.7) |
FNCLCC grade | |
 1 | 17 (17.2) |
 2 | 50 (50.5) |
 3 | 32 (32.3) |
Histological subtype | |
 MFH | 35 (35.4) |
 Myxoid liposarcoma | 26 (26.3) |
 Synovial sarcoma | 10 (10.1) |
 Dedifferentiated liposarcoma | 8 (8.1) |
 Myxofibrosarcoma | 5 (5.1) |
 Fibrosarcoma | 5 (5.1) |
 MPNST | 5 (5.1) |
 Ewing sarcoma/ PNET | 5 (5.1) |
Resection margin | |
 Negative | 77 (77.8) |
 Close (≤2 mm) | 9 (9.1) |
 Positive | 10 (10.1) |
 Unknowna | 3 (3.0) |
Treatment modality | |
 Surgery + RT | 58 (58.6) |
 Surgery + RT + CXT | 41 (41.4) |
RT dose (Gy) | |
 Median | 60 |
 Range | 46–66 |